What Are the Challenges of Targeting Vascular Supply?
One of the main challenges is that tumors can develop resistance to anti-angiogenic therapies. They may activate alternative pathways to continue angiogenesis or adapt to the hypoxic (low oxygen) environment by becoming more aggressive. Furthermore, inhibiting angiogenesis can sometimes lead to increased tumor invasion and metastasis.
